Table 1. Examples of Viruses and Viral Proteins Activating the Mitochondrial Pathway of Apoptosis.
Virus | Effector | Cellular Target | Effects | Reference |
Direct inducers of MMP | ||||
AEV | 2C | CEB and Cos-7 cells | Induction of the caspase cascade leading to apoptosis | [S154] |
VP3 | Different cell lines | Induction of the caspase cascade leading to apoptosis | [S153] | |
BLV | G4 | HeLa and yeast cells | Alterations of mitochondrial morphology; interacts with FPPS | [S140] |
HBV | HBx | Hepatocytes VDAC | Δψm loss and MMP-dependent apoptosis | [S122–S124] |
HCV | NS4A | Hepatocytes | Accumulation in mitochondria, Δψm loss, Cyt c release, casp-3 activation | [S155] |
HIV-1 | Vpr | CD4+ lymphocytes ANT/VDAC | Δψm loss, IMS proteins release, caspase cascade activation | [24;S41,S113,S115] |
HTLV-1 | p13(II) | Lymphocytes | Rapid flux of K+ and Ca2+ across IM, swelling, Δψm dissipation and fragmentation | [S135,S138] |
HPV | E1̂E4 | Keratinocytes | Displaces mitochondria from microtubules | [S152] |
IAV | PB1-F2 | Lung cells ANT3/VDAC1 | Interaction with ANT3 and VDAC1 | [S149] |
PLV | Unknown | Neurons Bone marrow Lymphoid cells | JNK activation, Cyt c release, Δψm loss, Bax activation | [S176] |
2B 3A | Kidney cells | Perinuclear aggregation and ultrastructural alterations of mitochondria, Δψm loss | [S130] | |
WDSV | OrfC | Epithelial cells | Perinuclear clustering of mitochondria, Δψm loss, partial Cyt c release, signs of apoptosis | [S131,S132] |
Indirect MMP Facilitators | ||||
ADV | E1A E4orf6 | Epithelial cells | Inhibition of PP2A, PARP hyperactivation, AIF translocation; sensitization to TNFα and Fas; BH3-only protein expression | [41;S183,S187] |
EBV | BALF1 | Lymphoid cells | Antagonism of BHRF1(?) | [67] |
FMDV | Unknown | Thyroid cells Kidney cells Dendritic cells | Reduction in the endogenous levels of Bcl-2, activation of caspases, release of Cyt c from mitochondria | [S206] |
HCV | NS3 | Hepatocytes | Casp-8-mediated apoptosis | [S171] |
HIV-1 | Env | CD4+ lymphocytes | Bax upregulation, Cyt c release, caspase activation; involvement of Cdk1, mTOR, p53 and NF-kB | [32,33;S160] |
Nef | Lymphocytes | Lysosomal membrane permeabilization, cathepsin D release, Bax activation, MMP-dependent cell death | [S158,S159] | |
Protease | Lymphocytes Bcl-2/Casp-8 | Bcl-2 depletion, NF-kB activation; Casp-8 activation, Bid cleavage, Cyt c release, Casp-9 and -3 activation, DFF and PARP cleavage | [36;S169] | |
Tat | Neurons Tubulin | Accumulation at mitochondria, Δψm loss, ROS overproduction, caspase activation; degradation of MAP2; Bim activation; regulation of p53, Bax and Bcl-2 | [34,35;S86,S161–S163,S165–S166] | |
HPV | E6 | Epithelial cells | Sensitize cells to different apoptotic stimuli, via mechanisms that may depend or not on p53 | [S191–S193] |
E7 | Epithelial cells | Sensitization of cells to apoptosis induced by growth factor withdrawal, chemotherapeutic agents and UV rays | [S194–S196] | |
PLV | 2Apro 3Cpro | HeLa cells | Caspase-dependent apoptosis | [S172,S173] |
SARS-CoV | 7a | Various cell lines | Inhibition of Bcl-XL | [46] |
VSV | M | Vero cells | Reduction of Bcl-XL levels; caspase activation | [44;S199] |
P | Hamster cells | Unknown mechanism | [S203] | |
WNV | Capsid NS2B/NS3 | Neurons | UPR, Bid and Bax translocation to mitochondria, Δψm dissipation, Cyt c release, caspase activation | [45;S207–S210] |
Abbreviations: ADV, adenovirus; AEV, avian encephalomyelitis virus; AIF, apoptosis-inducing factor; ANT, adenine nucleotide translocase; BH3, Bcl-2 homology domain 3; BLV, bovine leukemia virus; Casp, caspase; Cdk1, cyclin-dependent kinase 1; CEB, chick embryo brain; Cyt c, cytochrome c; Δψm, mitochondrial transmembrane potential; DFF, DNA fragmentation factor; EBV, Epstein-Barr virus; Env, envelope glycoprotein complex; FMDV, foot-and-mouth disease virus; FPPS, farnesyl pyrophosphate synthetase; HBV, hepatitis B virus; HBx, HBV X protein, HCV, hepatitis C virus; HIV-1, human immunodeficiency virus 1; HPV, human papillomavirus; HTLV-1, human T lymphotropic virus 1; IAV, influenza A virus; IMS, mitochondrial intermembrane space; JNK, c-Jun N-terminal kinase; M, matrix protein; MAP2, microtubule-associated protein 2; MMP, mitochondrial membrane permeabilization; mTOR, mammalian target of rapamycin; NF-kB, nuclear factor-kappa B; NS; non structural protein; ORF, open reading frame; P, phosphoprotein P; PARP, poly(ADP-ribose) polymerase; PLV, poliovirus; PP2A, protein phosphatase 2A; ROS, reactive oxygen species; SARS-CoV; severe acute respiratory syndrome coronavirus; TNFα, tumor necrosis factor α; UPR, unfolded protein response; UV, ultraviolet; VDAC, voltage-dependent anion channel; Vpr, viral protein R; VSV, vesicular stomatitis virus; WDSV, Walleye dermal sarcoma virus; WNV, West Nile virus.